SCHEMBL9690283

SCHEMBL9690283

Nc1[nH]c2ccccc2c1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.62
TDP1 Q9NUW8 1/20 0.62
APP P05067 1/20 0.49
KMT2A Q03164 5/20 0.47
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 4/20 0.47
HPGD P15428 3/20 0.47
GAA P10253 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
CYP1A2 P05177 1/20 0.47
GLA P06280 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
AHR P35869 1/20 0.47
CHRNA7 P36544 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3203918 0.85 KDM4E (0.49) KDM4ETDP1KMT2AALDH1A1MEN1
SCHEMBL8678798 0.81 KDM4E (0.74) KDM4ETDP1APPKMT2AALDH1A1
SCHEMBL1807094 0.79 NR4A2 (0.69) KDM4EKMT2AALDH1A1MEN1HPGD
SCHEMBL17559719 0.78 MEN1 (0.65) KDM4ETDP1KMT2AALDH1A1MEN1
SCHEMBL87871 0.78 KDM4E (0.65) KDM4ETDP1APPKMT2AALDH1A1
SCHEMBL27677910 0.78 KDM4E (0.65) KDM4ETDP1APPKMT2AALDH1A1
SCHEMBL29415434 0.77 KDM4E (1.00) KDM4ETDP1APPKMT2AALDH1A1
SCHEMBL2805779 0.77 KDM4E (1.00) KDM4ETDP1APPKMT2AALDH1A1
SCHEMBL570154 0.77 NR4A2 (0.67) KDM4ETDP1KMT2AALDH1A1MEN1
SCHEMBL11824092 0.77 KDM4E (0.62) KDM4ETDP1APPKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103906732-A Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof CHONG KUN DANG PHARM CORP 2014-07-02 CN disclosed
CN-1137100-C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family ��ʲ 2004-02-04 CN disclosed
CN-1139430-A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family WARNER LAMBERT CO (US) 1997-01-01 CN disclosed
EP-0249301-B1 Pyrido[2,3-b]indoles BEECHAM GROUP PLC (GB) 1992-05-27 EP disclosed
US-4952584-A TREATMENT OF PROPHYLAXIS OF ANXIETY OR DEPRESSION BEECHAM GROUP P.L.C. (GB) 1990-08-28 US disclosed
EP-0249301-A1 Pyrido[2,3-b]indoles BEECHAM GROUP PLC (GB) 1987-12-16 EP disclosed